D46.0
Refractory anemia without ring sideroblasts, so stated
Clinical Classification Guidelines
Inclusion Terms
- Refractory anemia without sideroblasts, without excess of blasts
Medical Intelligence & Overview
Refractory anemia without ring sideroblasts (ICD-10 Code D46.0) is a type of anemia characterized by a deficiency of healthy red blood cells in the bloodstream. This form of anemia does not feature ring sideroblasts, which are abnormal red blood cell precursors seen in some other types of sideroblastic anemia. It is considered a form of myelodysplastic syndrome, a group of disorders caused by poorly formed or dysfunctional blood cells. Patients with this condition often experience persistent anemia that resists standard treatments, leading to fatigue and other related symptoms. Early diagnosis and ongoing management are essential to improve quality of life and monitor for potential progression to more severe blood disorders.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting blood cell production Environmental exposures such as radiation or certain chemicals Previous chemotherapy or radiation therapy Idiopathic factors with no identifiable cause Age-related changes in bone marrow function
Key Symptoms: Chronic fatigue and weakness Pale skin and mucous membranes Shortness of breath upon exertion Dizziness or lightheadedness Increased heart rate Cold hands and feet Headaches and irritability
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of blood tests and bone marrow examination. These may include:
Treatment Protocols: Management of refractory anemia without ring sideroblasts focuses on alleviating symptoms and monitoring disease progression. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is D46.0 a billable ICD-10 code?
Yes, D46.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D46.0?
Clinical documentation must specify the nature of Refractory anemia without ring sideroblasts, so stated and any associated comorbidities for accurate reporting.
Cite this Clinical Reference